Guardant Health grows with Shield blood CRC screening, Quest deal, 50M reach, 335% surge, and FY25 revenue $981M up 33%. Read ...

Rhythm Biosciences Ltd ('RHY', the 'Company' or the 'Group') (ASX: RHY), a transformative, predictive cancer diagnostics technology company is pleased to announce the commercial launch of its updated ...

A digital rectal exam (DRE) is a way to check for signs of prostate cancer. For this exam a physician inserts a gloved, lubricated finger into your rectum to: Feel your prostate gland Assess the ...

The Food and Drug Administration (FDA) has recently approved a blood test that can assist in the primary detection of colorectal cancer. This test could assist with prompt detection and intervention ...

It’s good news in the fight against colorectal cancer: A new test can detect the disease with a simple blood draw. But don’t cancel your colonoscopy just yet — that old standby is still more reliable ...

Saga Diagnostics expanded the use of its ultrasensitive blood test to include detection of tiny amounts of colorectal cancer ...

The Food and Drug Administration approved a blood test that can detect colorectal cancer, CBS News reported. It’s called Shield and was developed by Guardant Health Inc. The test was approved by the ...

A simple blood test could detect colorectal cancer (CRC) with more than 80% accuracy, according to a new study coauthored by researchers at the Fred Hutchinson Cancer Center in Seattle, Washington.

“Blood-based screening tests are more acceptable to people than colonoscopy and stool tests and likely will increase screening compliance,” said the study’s corresponding author, Dr. William Grady, a ...

For the first time, the U.S. Food and Drug Administration has approved a blood test as a primary screening option for colorectal cancer. Guardant Health's Shield blood test was approved Monday as a ...

For 10% of colorectal cancer patients, hereditary factors play a role, with higher percentages among younger patients.

A new blood test that screens for colorectal cancer has just been approved by the Food and Drug Administration (FDA). The blood sample needed for the new test, called Shield, can be obtained at a ...